Written question asked by Caroline Spelman (Conservative) on Tuesday, 13 March 2001, in the House of Commons. It was due for an answer on Monday, 19 March 2001. It was answered by Baroness Stuart of Edgbaston (Labour) on Monday, 19 March 2001 on behalf of the Department of Health.

Dept of Health

Question: To ask the Secretary of State for Health, how much public money has been spent on the AD2000 Study of the effectiveness of donepezil in each of the years (a) 1998, (b) 1999, (c) 2000 and (d) 2001, broken down by (i) the amount spent by individual health authorities on the trial, (ii) the amount allocated to the trial from regional research and development budgets, (iii) the amount allocated from the national research and development extra treatment costs fund and (iv) other NHS costs incurred as a result of the trial. - Includes table and ref to information is not available in the format requested. (Holding answer 16 March 2001).

Answer: Mrs. Spelman: To ask the Secretary of State for Health how much public money has been spent on the AD2000 study of the effectiveness of donepezil in each of the years (a) 1998, (b) 1999, (c) 2000 and (d) 2001, broken down by (i) the amount spent by individual health authorities on the trial, (ii) the amount allocated to the trial from regional research and development budgets, (iii) the amount allocated from the national research and development extra treatment costs fund and (iv) other NHS costs incurred as a result of the trial. [154072] Ms Stuart: [holding answer 16 March 2001]: The information is not available in the format requested. The Department has been sponsoring a trial on the long-term effectiveness of donepezil (ARICEPT). The table shows expenditure from the west midlands regional office of the national health service executive and the excess treatment costs budget for this trial. £ _________________________________________________________________________________________________. West midlands regional office Excess treatment costs 1997-98 5,000 -- 1998-99 122,412 -- 1999-2000 245,870 -- 2000-01 225,723 145,000 2001-02 224,973 {1}200,000 _________________________________________________________________________________________________. {1} Estimate

Secondary information

Type: Written question
Reference: 365 c100-1W; 154072
Session: 2000-01
Subjects: Finance Expenditure Health authorities NHS Prescription drugs Research Clinical trials West Midlands Health Region Donepezil
Contains statistics: Yes
Link: View this Written question on www.publications.parliament.uk